Clinical Trial: A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07600450) titled 'A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive' on May 14.

Brief Summary: This is a first time in Asia (FTIA) study of GSK4771261 in healthy participants of Chinese, Japanese, and White/European ancestry. The study will test whether GSK4771261 is safe, well-tolerated, how it is processed in the body, and whether it triggers an immune response.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Kidney Disease

Intervention: DRUG: GSK4771261

GSK4771261 will be administered.

DRUG: Placebo

Placebo will be administered.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: GlaxoSmithKlin...